Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Waldvogel
F A
FA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D008712:Methicillin / Q000494:pharmacology* / Q000627:therapeutic use; D010403:Penicillin Resistance; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*; D013307:Streptomycin / Q000627:therapeutic use; D014640:Vancomycin / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004917:Erythromycin; D014640:Vancomycin; D008712:Methicillin; D012293:Rifampin; D013307:Streptomycin